Thorac Cardiovasc Surg 2018; 66(S 01): S1-S110
DOI: 10.1055/s-0038-1627959
Oral Presentations
Monday, February 19, 2018
DGTHG: Congenital – Surgery
Georg Thieme Verlag KG Stuttgart · New York

Modified Pediatric Full Blood Cardioplegia Is Not Inferior to Classic Cold Crystalloid Cardioplegia in the Surgical Repair of Septal Defects

A. Purbojo
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
,
N. Kläver
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
,
F. Münch
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
,
R. Blumauer
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
,
R. Cesnjevar
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
,
A. Rüffer
1   Kinderherzchirurgische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
22 January 2018 (online)

Background: Myocardial protection for longer aortic cross clamping periods is usually ensured with cardioplegia. The purpose of this retrospective study was to evaluate the feasibility and safety of tepid modified full blood cardioplegia (MBC) adapted to pediatric metabolism for surgical repair of simple septal defects compared with a standard cold crystalloid cardioplegia (CCC/Custodiol).

Methods: Observational clinical, hemodynamic and laboratory data of 64 retrospectively enrolled patients with simple septal defects (ASD, n = 34, VSD, n = 32) were matched according to diagnosis and body surface area. MBC (Calafiore cardioplegia enriched with electrolytes) was applied for 2 minutes and repeated every 20 minutes. CCC was given as a single shot and repeated every 60 minutes in longer clamping periods. Intraoperative hemodynamic evaluation of cardiac output and cardiac index was performed by aortic flow measurement before aortic cross clamping (T1), after bypass (T2) and after modified ultrafiltration (T3). Measurement of standard cardiac markers included Troponin-T (TnT) and CKMB at T1, T3 and first postoperative day (T4).

Results: Patient pairs did not statistically differ in aortic cross clamping time and bypass time. There was no operative mortality. At given observation points cardiac index and cardiac markers did not differ between groups.

Table 1

MBC

CCC

p-Value

T1

Trop T (ng/mL)

0.013 (0.01–0.05)

0.021 (0.01–0.11)

0.142

CKMB (μg/L)

3.5 (1.9–13.0)

5.2 (1.9–13.0)

0.952

CI (L/min/m2)

2.8 (1.39–4.15)

2.6 (1.44–2.53)

0.279

T2

CI (L/min/m2)

3.4 (1.77–5.39)

2.9 (1.23–5.19)

0.949

T3

Trop T (ng/ mL)

3.2 (0.34–18)

4.2 (0.03–25)

0.152

CKMB (μg/L)

144.6 (31–415)

167.9 (8.7–455)

0.642

CI (L/min/m2)

3.4 (1.62–5.4)

3.3 (1.84–5.58)

0.854

T4

Trop T (ng/ mL)

0.9 (0.25–2.8)

1.23 (0.27–3.0)

0.172

CKMB (μg/L)

51.5 (5–100)

62.2 (28–140)

0.751

Conclusion: This study indicates that tepid MBC preserves myocardial function as good as CCC during aortic cross-clamping in the context of corrective pediatric heart surgery for simple septal defects. Further studies are needed to evaluate possible beneficial effects of modified pediatric blood cardioplegia for larger patient groups.